These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 11076880)

  • 1. Sulindac and a cyclooxygenase-2 inhibitor, etodolac, increase APC mRNA in the colon of rats treated with azoxymethane.
    Kishimoto Y; Takata N; Jinnai T; Morisawa T; Shiota G; Kawasaki H; Hasegawa J
    Gut; 2000 Dec; 47(6):812-9. PubMed ID: 11076880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane.
    Kishimoto Y; Morisawa T; Hosoda A; Shiota G; Kawasaki H; Hasegawa J
    J Exp Clin Cancer Res; 2002 Jun; 21(2):203-11. PubMed ID: 12148579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of long-term administration of sulindac on APC mRNA and apoptosis in colons of rats treated with azoxymethane.
    Kishimoto Y; Yashima K; Morisawa T; Ohishi T; Marumoto A; Sano A; Idobe-Fujii Y; Miura N; Shiota G; Murawaki Y; Hasegawa J
    J Cancer Res Clin Oncol; 2002 Nov; 128(11):589-95. PubMed ID: 12458338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
    Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
    Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cyclooxygenase-2 inhibitor NS-398 on APC and c-myc expression in rat colon carcinogenesis induced by azoxymethane.
    Kishimoto Y; Yashima K; Morisawa T; Shiota G; Kawasaki H; Hasegawa J
    J Gastroenterol; 2002; 37(3):186-93. PubMed ID: 11931531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of azoxymethane-induced aberrant crypt foci in rat colon by nimesulide, a selective inhibitor of cyclooxygenase 2.
    Takahashi M; Fukutake M; Yokota S; Ishida K; Wakabayashi K; Sugimura T
    J Cancer Res Clin Oncol; 1996; 122(4):219-22. PubMed ID: 8601574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of NS-398, a selective cyclooxygenase-2 inhibitor, on azoxymethane-induced aberrant crypt foci in colon carcinogenesis of F344 rats.
    Yoshimi N; Kawabata K; Hara A; Matsunaga K; Yamada Y; Mori H
    Jpn J Cancer Res; 1997 Nov; 88(11):1044-51. PubMed ID: 9439679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis.
    Reddy BS; Rao CV; Seibert K
    Cancer Res; 1996 Oct; 56(20):4566-9. PubMed ID: 8840961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potentiates chemopreventive effects of sulindac.
    Agarwal B; Rao CV; Bhendwal S; Ramey WR; Shirin H; Reddy BS; Holt PR
    Gastroenterology; 1999 Oct; 117(4):838-47. PubMed ID: 10500066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemopreventive effect of N-(2-cyclohexyloxy-4-nitrophenyl)methane sulfonamide (NS-398), a selective cyclooxygenase-2 inhibitor, in rat colon carcinogenesis induced by azoxymethane.
    Yoshimi N; Shimizu M; Matsunaga K; Yamada Y; Fujii K; Hara A; Mori H
    Jpn J Cancer Res; 1999 Apr; 90(4):406-12. PubMed ID: 10363578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rat colorectal tumours treated with a range of non-steroidal anti-inflammatory drugs show altered cyclooxygenase-2 and cyclooxygenase-1 splice variant mRNA expression levels.
    Vogiagis D; Brown W; Glare EM; O'Brien PE
    Carcinogenesis; 2001 Jun; 22(6):869-74. PubMed ID: 11375891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing the effects of COX and non-COX-inhibiting NSAIDs on enhancement of apoptosis and inhibition of aberrant crypt foci formation in a rat colorectal cancer model.
    Martin JE; Young GP; LE Leu RK; Hu Y
    Anticancer Res; 2013 Sep; 33(9):3581-8. PubMed ID: 24023283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.
    Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S
    Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemopreventive efficacy of sulindac sulfone against colon cancer depends on time of administration during carcinogenic process.
    Reddy BS; Kawamori T; Lubet RA; Steele VE; Kelloff GJ; Rao CV
    Cancer Res; 1999 Jul; 59(14):3387-91. PubMed ID: 10416599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of apoptosis by sulindac in azoxymethane-induced possible colonic premalignant lesions in rats.
    Kuno T; Yamada Y; Hirose Y; Katayama M; Sakata K; Hara A; Saji S; Mori H
    Jpn J Cancer Res; 2002 Mar; 93(3):242-6. PubMed ID: 11927004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary fat and colon cancer: modulation of cyclooxygenase-2 by types and amount of dietary fat during the postinitiation stage of colon carcinogenesis.
    Singh J; Hamid R; Reddy BS
    Cancer Res; 1997 Aug; 57(16):3465-70. PubMed ID: 9270014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do NSAIDs exert their colon cancer chemoprevention activities through the inhibition of mucosal prostaglandin synthetase?
    Alberts DS; Hixson L; Ahnen D; Bogert C; Einspahr J; Paranka N; Brendel K; Gross PH; Pamukcu R; Burt RW
    J Cell Biochem Suppl; 1995; 22():18-23. PubMed ID: 8538196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coordinate regulation of cyclooxygenase-2 and TGF-beta1 in replication error-positive colon cancer and azoxymethane-induced rat colonic tumors.
    Shao J; Sheng H; Aramandla R; Pereira MA; Lubet RA; Hawk E; Grogan L; Kirsch IR; Washington MK; Beauchamp RD; DuBois RN
    Carcinogenesis; 1999 Feb; 20(2):185-91. PubMed ID: 10069452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulindac increases the expression of APC mRNA in malignant colonic epithelial cells: an in vitro study.
    Schnitzler M; Dwight T; Robinson BG
    Gut; 1996 May; 38(5):707-13. PubMed ID: 8707116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids.
    Rao CV; Hirose Y; Indranie C; Reddy BS
    Cancer Res; 2001 Mar; 61(5):1927-33. PubMed ID: 11280748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.